Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 13, 2004, to announce preliminary, unaudited sales results for the fourth quarter and full year ended December 31, 2003. This filing provides investors with an early look at the company's performance for the recently concluded fiscal year and the final quarter, allowing for an initial assessment of revenue trends and the company's market position. The information is furnished as an exhibit to the 8-K, though it's important to note that this specific information is not considered "filed" for the purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same liability as formally filed information. Investors should review the press release for detailed sales figures and commentary on the company's operational and financial condition during this period.
Key Highlights
- 1Boston Scientific announced preliminary, unaudited sales results for Q4 and full year 2003.
- 2The announcement was made via a press release furnished with the 8-K filing.
- 3The filing date is January 13, 2004, with the earliest event date also being January 13, 2004, indicating the announcement was made on or before the filing date.
- 4The report covers the fourth quarter and the full year ended December 31, 2003.
- 5The information provided is preliminary and unaudited, requiring investors to exercise caution in their analysis.
- 6This filing serves to inform stakeholders about recent sales performance, which is a key indicator of business health.